Clinical trial
Study to Evaluate the Clinical Benefit Response in Cancer Patients With Advanced…
NCT00332280 · Auron Healthcare GmbH, Industry · Terminated
Key facts
| NCT number | NCT00332280 |
|---|---|
| Title | Study to Evaluate the Clinical Benefit Response in Cancer Patients With Advanced Disease With AMT2003 Versus Placebo |
| Official title | A Prospective, Randomised, Multicenter Phase II/III Clinical Trial to Evaluate the Clinical Benefit Response in Cancer Patients With Advanced Disease With AMT Versus Placebo |
| Lead sponsor | Auron Healthcare GmbH, Industry |
| Status | Terminated |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Gastrointestinal Cancer, Prostate Cancer, Genital Neoplasms, Female |
| Intervention type | Drug |
| Interventions | AMT2003 |
| Enrollment | 67 |
| Start date | May 1, 2006 |
| Primary completion | Jan 1, 2010 |
| Completion | Mar 1, 2010 |
| First posted | Jun 1, 2006 |
| Last update posted | Mar 20, 2013 |
| Countries | Bosnia and Herzegovina, Germany |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: